Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Park Ha Biological Technology ( (BYAH) ) just unveiled an announcement.
On January 27, 2026, Park Ha Biological Technology Co., Ltd. priced a best-efforts follow-on public offering of 21,875,000 units at US$0.112 per unit, each comprising one Class A ordinary share and a one-year warrant with the same exercise price, under an effective SEC-registered Form F-1. The deal, placed by D. Boral Capital LLC, closed on January 28, 2026 and raised approximately US$2.45 million in gross proceeds before fees, with the company planning to deploy the funds to expand its network of directly operated skincare stores across China, signalling a continued push to scale its retail footprint and strengthen its market presence alongside its existing franchise base.
More about Park Ha Biological Technology
Park Ha Biological Technology Co., Ltd., founded in 2016 and listed on Nasdaq, operates in China’s skincare and beauty services industry, focusing on developing and selling its proprietary “Park Ha” skincare brand through a mix of directly operated stores and franchise outlets. As of April 30, 2025, the company ran three self-operated stores and supported 39 franchisees under the “Park Ha” and “Geni” banners, offering value-added “light beauty experience” after-sales services to women seeking cost-effective skin treatment solutions.
Average Trading Volume: 260,749
Technical Sentiment Signal: Strong Sell
Current Market Cap: $4.95M
For detailed information about BYAH stock, go to TipRanks’ Stock Analysis page.